| Frank M Elders, DO | |
|
1000 W 10th St, Rolla, MO 65401-2905 | |
| (573) 364-3100 | |
| Not Available |
| Full Name | Frank M Elders |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 1000 W 10th St, Rolla, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104869221 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | DO34494 (Missouri) | Primary |
| Entity Name | Phelps County Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891766051 PECOS PAC ID: 2860391158 Enrollment ID: O20040106000405 |
News Archive
Approximately 5,000 families (pregnant women, fathers and newborns) are being asked to take part in a new study called Étude 3-D (Découvrir, Développer, Devenir) that is aimed at understanding the effects of perinatal events on child development. The study is directed by Dr. William Fraser, Associate Director of Clinical Research at the CHU Sainte-Justine and professor of Medicine at the University of Montreal.
Contrary to the prevailing view, the hormone leptin, which is critical for normal food intake and metabolism, appears to regulate bone mass and suppress appetite by acting mainly through serotonin pathways in the brain, according to a recent study published in Cell by Yale School of Medicine researchers and colleagues at Columbia University. This new finding contradicts the view that leptin acts primarily in the hypothalamus.
Repros Therapeutics (Nasdaq:RPRX) today announced that Repros has entered into a definitive agreement with a single institutional investor to sell 1.5 million shares of its common stock at $0.65 per share for gross proceeds of approximately $1.0 million.
Magellan Health Services Inc. has announced that ICORE Healthcare, its Specialty Pharmaceutical division, has been awarded the Specialty Pharmacy Accreditation from URAC, a Washington, D.C. based health care accrediting organization that establishes quality standards for the health care industry.
ViroPharma Incorporated today announced the license of worldwide rights from Intellect Neurosciences, Inc. to its clinical stage drug candidate, OX1, being developed for the treatment of Friedreich's Ataxia (FA), a rare, hereditary, progressive neurodegenerative disease.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Frank M Elders, DO 10737 Highway 19, Cuba, MO 65453-7170 Ph: () - | Frank M Elders, DO 1000 W 10th St, Rolla, MO 65401-2905 Ph: (573) 364-3100 |
News Archive
Approximately 5,000 families (pregnant women, fathers and newborns) are being asked to take part in a new study called Étude 3-D (Découvrir, Développer, Devenir) that is aimed at understanding the effects of perinatal events on child development. The study is directed by Dr. William Fraser, Associate Director of Clinical Research at the CHU Sainte-Justine and professor of Medicine at the University of Montreal.
Contrary to the prevailing view, the hormone leptin, which is critical for normal food intake and metabolism, appears to regulate bone mass and suppress appetite by acting mainly through serotonin pathways in the brain, according to a recent study published in Cell by Yale School of Medicine researchers and colleagues at Columbia University. This new finding contradicts the view that leptin acts primarily in the hypothalamus.
Repros Therapeutics (Nasdaq:RPRX) today announced that Repros has entered into a definitive agreement with a single institutional investor to sell 1.5 million shares of its common stock at $0.65 per share for gross proceeds of approximately $1.0 million.
Magellan Health Services Inc. has announced that ICORE Healthcare, its Specialty Pharmaceutical division, has been awarded the Specialty Pharmacy Accreditation from URAC, a Washington, D.C. based health care accrediting organization that establishes quality standards for the health care industry.
ViroPharma Incorporated today announced the license of worldwide rights from Intellect Neurosciences, Inc. to its clinical stage drug candidate, OX1, being developed for the treatment of Friedreich's Ataxia (FA), a rare, hereditary, progressive neurodegenerative disease.
› Verified 4 days ago
David Lamont White, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1000 W 10th St, Rolla, MO 65401 Phone: 573-364-3100 | |
Lori Michelle Smith, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1050 W 10th St, Rolla, MO 65401 Phone: 573-364-9000 | |
Margaret Elizabeth Rallo, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 W 10th St Dept Of, Rolla, MO 65401 Phone: 573-458-7800 | |
Dr. Tuere A Franklin, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1000 W 10th St, Rolla, MO 65401 Phone: 573-458-8899 | |
Dr. Karen Sue Jiles, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1000 W 10th St, Rolla, MO 65401 Phone: 573-458-7800 |